908 Devices Crescita futura
Criteri Future verificati 1/6
Si prevede che 908 Devices aumenterà gli utili e i ricavi rispettivamente del 44.3% e 19.1% all'anno, mentre si prevede che l'EPS crescerà del 46.6% all'anno.
Informazioni chiave
44.3%
Tasso di crescita degli utili
46.61%
Tasso di crescita dell'EPS
| Electronic crescita degli utili | 26.7% |
| Tasso di crescita dei ricavi | 19.1% |
| Rendimento futuro del capitale proprio | n/a |
| Copertura analitica | Low |
| Ultimo aggiornamento | 07 May 2026 |
Aggiornamenti recenti sulla crescita futura
Recent updates
908 Devices Looking Better Now (Rating Upgrade)
Summary 908 Devices delivered strong Q1 results, raising full-year revenue guidance after a strategic acquisition in narcotics detection. Adjusted gross margins improved nearly three percentage points to 57%, and operating cash flow turned positive. MASS has a solid balance sheet with nearly $100 million in cash post-acquisition and is debt free, while trading at a reasonable valuation. Read the full article on Seeking Alpha
MASS: Raised 2026 Revenue Guidance Will Support Higher Earnings Multiple
Analysts have reset their price target on 908 Devices to $10.00 from $8.00, citing updated assumptions around revenue growth, profitability, and future P/E that feed into a higher fair value estimate and a modestly higher discount rate. What's in the News 908 Devices raised full year 2026 revenue guidance to a range of $67.0 million to $70.0 million, compared with 2025 revenue, with the range described as representing 19% to 25% growth (Corporate Guidance: Raised).908 Devices Inc.'s (NASDAQ:MASS) 29% Price Boost Is Out Of Tune With Revenues
Those holding 908 Devices Inc. ( NASDAQ:MASS ) shares would be relieved that the share price has rebounded 29% in the...Some 908 Devices Inc. (NASDAQ:MASS) Shareholders Look For Exit As Shares Take 26% Pounding
908 Devices Inc. ( NASDAQ:MASS ) shareholders won't be pleased to see that the share price has had a very rough month...908 Devices Inc.'s (NASDAQ:MASS) Share Price Not Quite Adding Up
When close to half the companies in the Electronic industry in the United States have price-to-sales ratios (or "P/S...908 Devices Inc. (NASDAQ:MASS) Analysts Are Pretty Bullish On The Stock After Recent Results
NasdaqGM:MASS 1 Year Share Price vs Fair Value Explore 908 Devices's Fair Values from the Community and select yours...
US Federal And International Funding Will Expand Global Analysis Markets
The notable increase in 908 Devices’ price target reflects improved outlook due to higher expected revenue growth and an expanded forward P/E, raising the consensus fair value from $6.50 to $9.00. What's in the News 908 Devices raised its 2025 revenue guidance to $54–56 million (13–17% growth), up from prior guidance of $53–55 million.908 Devices Inc.'s (NASDAQ:MASS) Shares Climb 26% But Its Business Is Yet to Catch Up
Despite an already strong run, 908 Devices Inc. ( NASDAQ:MASS ) shares have been powering on, with a gain of 26% in the...
The New Handheld Mass Spectrometer Launch Will Expand Market Reach
Divesting the desktop bioprocessing portfolio boosts cash reserves, streamlines operations, and is expected to enhance margins and cash flow in future years.908 Devices Makes Key Divestiture (Rating Upgrade)
Summary 908 Devices' stock surged after announcing a $70 million desktop portfolio sale, doubling its cash position and improving financial stability. The company will now focus on its handheld device business, expecting 11% to 15% revenue growth in 2025 with acceleration in 2026. MASS management believes losses will be significantly reduced with the new structure, with positive cash flow next year. Read the full article on Seeking Alpha908 Devices Inc.'s (NASDAQ:MASS) 55% Jump Shows Its Popularity With Investors
The 908 Devices Inc. ( NASDAQ:MASS ) share price has done very well over the last month, posting an excellent gain of...Earnings Update: 908 Devices Inc. (NASDAQ:MASS) Just Reported And Analysts Are Trimming Their Forecasts
The analysts might have been a bit too bullish on 908 Devices Inc. ( NASDAQ:MASS ), given that the company fell short...908 Devices: Key Investor Now Selling
Summary ARK Invest's recent sales of 908 Devices shares have helped to send the stock to multi-year lows. 908 Devices is seeing decent revenue growth, but large losses and limited financial flexibility raise concerns about future capital needs. The stock's low valuation compared to peers is a positive, but ongoing sales by ARK Invest could exert further downward pressure. Read the full article on Seeking AlphaWhy We're Not Concerned Yet About 908 Devices Inc.'s (NASDAQ:MASS) 29% Share Price Plunge
To the annoyance of some shareholders, 908 Devices Inc. ( NASDAQ:MASS ) shares are down a considerable 29% in the last...We Think 908 Devices (NASDAQ:MASS) Can Afford To Drive Business Growth
We can readily understand why investors are attracted to unprofitable companies. For example, although Amazon.com made...Investors Appear Satisfied With 908 Devices Inc.'s (NASDAQ:MASS) Prospects
When you see that almost half of the companies in the Electronic industry in the United States have price-to-sales...908 Devices Q2 2022 Earnings Preview
908 Devices (NASDAQ:MASS) is scheduled to announce Q2 earnings results on Tuesday, August 9th, before market open. The consensus EPS Estimate is -$0.26 (+3.7% Y/Y) and the consensus Revenue Estimate is $10.79M (+30.5% Y/Y). Over the last 3 months, EPS estimates have seen 1 upward revision and 2 downward. Revenue estimates have seen 0 upward revisions and 2 downward.Previsioni di crescita degli utili e dei ricavi
| Data | Ricavi | Utili | Flusso di cassa libero | Liquidità dell'operazione | Avg. Numero di analisti |
|---|---|---|---|---|---|
| 12/31/2028 | 100 | -9 | N/A | N/A | 1 |
| 12/31/2027 | 82 | -17 | N/A | N/A | 4 |
| 12/31/2026 | 69 | -19 | N/A | N/A | 4 |
| 3/31/2026 | 58 | -35 | -8 | -7 | N/A |
| 12/31/2025 | 56 | -33 | -25 | -24 | N/A |
| 9/30/2025 | 65 | -73 | -28 | -27 | N/A |
| 6/30/2025 | 66 | -81 | -29 | -29 | N/A |
| 3/31/2025 | 52 | -57 | -36 | -36 | N/A |
| 12/31/2024 | 48 | -53 | -31 | -30 | N/A |
| 9/30/2024 | 48 | -45 | -31 | -30 | N/A |
| 6/30/2024 | 48 | -28 | -30 | -29 | N/A |
| 3/31/2024 | 48 | -30 | -26 | -24 | N/A |
| 12/31/2023 | 50 | -36 | -27 | -25 | N/A |
| 9/30/2023 | 48 | -39 | -31 | -28 | N/A |
| 6/30/2023 | 49 | -38 | -31 | -29 | N/A |
| 3/31/2023 | 48 | -37 | -34 | -31 | N/A |
| 12/31/2022 | 47 | -34 | -23 | -21 | N/A |
| 9/30/2022 | 51 | -27 | -27 | -25 | N/A |
| 6/30/2022 | 48 | -26 | -24 | -23 | N/A |
| 3/31/2022 | 45 | -25 | -21 | -20 | N/A |
| 12/31/2021 | 42 | -22 | -30 | -29 | N/A |
| 9/30/2021 | 32 | -29 | -18 | -18 | N/A |
| 6/30/2021 | 26 | -26 | -7 | -6 | N/A |
| 3/31/2021 | 28 | -18 | -2 | -2 | N/A |
| 12/31/2020 | 27 | -13 | 4 | 4 | N/A |
| 9/30/2020 | 30 | -3 | 2 | 2 | N/A |
| 6/30/2020 | 27 | -6 | -6 | -6 | N/A |
| 3/31/2020 | 19 | -11 | -9 | -9 | N/A |
| 12/31/2019 | 18 | -13 | N/A | -11 | N/A |
| 12/31/2018 | 22 | -8 | N/A | -9 | N/A |
Previsioni di crescita futura degli analisti
Guadagni vs tasso di risparmio: Si prevede che MASS rimarrà non redditizia nei prossimi 3 anni.
Guadagni vs Mercato: Si prevede che MASS rimarrà non redditizia nei prossimi 3 anni.
Guadagni ad alta crescita: Si prevede che MASS rimarrà non redditizia nei prossimi 3 anni.
Ricavi vs Mercato: Si prevede che il fatturato di MASS ( 19.1% all'anno) crescerà più rapidamente del mercato US ( 11.6% all'anno).
Ricavi ad alta crescita: Si prevede che il fatturato di MASS ( 19.1% all'anno) crescerà più lentamente di 20% all'anno.
Previsioni di crescita dell'utile per azione
Rendimento futuro del capitale proprio
ROE futuro: Dati insufficienti per determinare se il Return on Equity di MASS è previsto essere elevato tra 3 anni
Scoprire le aziende in crescita
Analisi aziendale e situazione dei dati finanziari
| Dati | Ultimo aggiornamento (ora UTC) |
|---|---|
| Analisi dell'azienda | 2026/05/19 05:33 |
| Prezzo dell'azione a fine giornata | 2026/05/19 00:00 |
| Utili | 2026/03/31 |
| Utili annuali | 2025/12/31 |
Fonti dei dati
I dati utilizzati nella nostra analisi aziendale provengono da S&P Global Market Intelligence LLC. I seguenti dati sono utilizzati nel nostro modello di analisi per generare questo report. I dati sono normalizzati, il che può comportare un ritardo nella disponibilità della fonte.
| Pacchetto | Dati | Tempistica | Esempio Fonte USA * |
|---|---|---|---|
| Dati finanziari della società | 10 anni |
| |
| Stime di consenso degli analisti | +3 anni |
|
|
| Prezzi di mercato | 30 anni |
| |
| Proprietà | 10 anni |
| |
| Gestione | 10 anni |
| |
| Sviluppi principali | 10 anni |
|
* Esempio per i titoli statunitensi, per i titoli non statunitensi si utilizzano forme e fonti normative equivalenti.
Se non specificato, tutti i dati finanziari si basano su un periodo annuale ma vengono aggiornati trimestralmente. Si tratta dei cosiddetti dati TTM (Trailing Twelve Month) o LTM (Last Twelve Month). Per saperne di più.
Modello di analisi e Snowflake
I dettagli del modello di analisi utilizzato per generare questo report sono disponibili sulla nostra pagina Github; abbiamo anche guide su come utilizzare i nostri report e tutorial su Youtube.
Scoprite il team di livello mondiale che ha progettato e realizzato il modello di analisi Simply Wall St.
Metriche di settore e industriali
Le nostre metriche di settore e di sezione sono calcolate ogni 6 ore da Simply Wall St; i dettagli del nostro processo sono disponibili su Github.
Fonti analitiche
908 Devices Inc. è coperta da 4 analisti. 4 di questi analisti ha fornito le stime di fatturato o di utile utilizzate come input per il nostro report. Le stime degli analisti vengono aggiornate nel corso della giornata.
| Analista | Istituzione |
|---|---|
| Puneet Souda | Leerink Partners LLC |
| Daniel Arias | Stifel, Equities Research |
| Brendan Smith | TD Cowen |